B

Belluscura PLC
LSE:BELL

Watchlist Manager
Belluscura PLC
LSE:BELL
Watchlist
Price: 10.25 GBX 7.89% Market Closed
Market Cap: 17.3m GBX
Have any thoughts about
Belluscura PLC?
Write Note

Belluscura PLC
Other Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Belluscura PLC
Other Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
B
Belluscura PLC
LSE:BELL
Other Operating Expenses
$33.9k
CAGR 3-Years
43%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Smith & Nephew PLC
LSE:SN
Other Operating Expenses
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
LivaNova PLC
NASDAQ:LIVN
Other Operating Expenses
$1m
CAGR 3-Years
N/A
CAGR 5-Years
-50%
CAGR 10-Years
N/A
EKF Diagnostics Holdings PLC
LSE:EKF
Other Operating Expenses
ÂŁ234k
CAGR 3-Years
13%
CAGR 5-Years
21%
CAGR 10-Years
-8%
Angle PLC
LSE:AGL
Other Operating Expenses
-ÂŁ20.8m
CAGR 3-Years
-7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Creo Medical Group PLC
LSE:CREO
Other Operating Expenses
ÂŁ400k
CAGR 3-Years
637%
CAGR 5-Years
25%
CAGR 10-Years
N/A
No Stocks Found

Belluscura PLC
Glance View

Market Cap
16.3m GBX
Industry
Health Care

Belluscura Plc engages in the provision of medical devices. The Company’s product, the X-PLO2R, is a lightweight portable oxygen concentrator (POC), which is designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. The company focuses on devices and treatments involving oxygen. The X-PLO2R DX is designed to produce approximately six-liters pulse dose oxygen and approximately two-liters of flow oxygen. The firm is focused on developing the medical devices for treating people who are suffering from chronic lung diseases, such as the chronic obstructive pulmonary disease (COPD), respiratory distress caused by coronavirus disease (COVID-19), and other respiratory disorders.

BELL Intrinsic Value
11.52 GBX
Undervaluation 11%
Intrinsic Value
Price
B

See Also

What is Belluscura PLC's Other Operating Expenses?
Other Operating Expenses
33.9k USD

Based on the financial report for Dec 31, 2023, Belluscura PLC's Other Operating Expenses amounts to 33.9k USD.

What is Belluscura PLC's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 3Y
43%

Over the last year, the Other Operating Expenses growth was 290%. The average annual Other Operating Expenses growth rates for Belluscura PLC have been 43% over the past three years .

Back to Top